About
Described as an “execution-driven businessman,” Gordon Chiu has combined domestic and international experience in the biomedical, chemical, cosmetic, medical, and technology industries. As President, Chief Technology Officer and co-founder of Grafoid Inc., Gordon Chiu is engaged in the discovery and research of graphene on behalf of Grafoid, as well as the development of graphene applications with Grafoid’s joint venture application development partners. He is also Focus Graphite Inc.’s Chief Scientist. Gordon Chiu is a former research scientist at Pfizer Inc. and Merck & Co., Inc. and has healthcare and marketing experience with strong links to Wall Street and Asia. Gordon Chiu holds a B.Sc. degree summa cum laude in chemistry from Rensselaer Polytechnic Institute, graduated with a M.Sc. degree in chemistry from Seton Hall University with honors, and is globally distinguished by his acceptance as an MD/PhD candidate under the National Institutes of Health’s Medical Scientist Training
Position in the VCSift Database
- • 17 investors hold the Co-Founder & Chief Technology Officer role in VCSift. Gordon Chiu is one of them.
- • 10,621 investors are based in New York, New York, United States.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- New York, US
Contact Information
Find more investors like Gordon
Search Investors